Dudkina E V, Ulyanova V V, Ilinskaya O N
Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, 420008 Russia.
Acta Naturae. 2020 Jul-Sep;12(3):24-33. doi: 10.32607/actanaturae.11000.
One of the approaches used to eliminate tumor cells is directed destruction/modification of their RNA molecules. In this regard, ribonucleases (RNases) possess a therapeutic potential that remains largely unexplored. It is believed that the biological effects of secreted RNases, namely their antitumor and antiviral properties, derive from their catalytic activity. However, a number of recent studies have challenged the notion that the activity of RNases in the manifestation of selective cytotoxicity towards cancer cells is exclusively an enzymatic one. In this review, we have analyzed available data on the cytotoxic effects of secreted RNases, which are not associated with their catalytic activity, and we have provided evidence that the most important factor in the selective apoptosis-inducing action of RNases is the structural organization of these enzymes, which determines how they interact with cell components. The new idea on the preponderant role of non-catalytic interactions between RNases and cancer cells in the manifestation of selective cytotoxicity will contribute to the development of antitumor RNase-based drugs.
用于消除肿瘤细胞的方法之一是直接破坏/修饰其RNA分子。在这方面,核糖核酸酶(RNases)具有很大程度上尚未被探索的治疗潜力。人们认为,分泌型核糖核酸酶的生物学效应,即它们的抗肿瘤和抗病毒特性,源于其催化活性。然而,最近的一些研究对核糖核酸酶在对癌细胞表现出选择性细胞毒性方面的活性完全是酶促活性这一观点提出了挑战。在这篇综述中,我们分析了关于分泌型核糖核酸酶细胞毒性作用的现有数据,这些作用与其催化活性无关,并且我们提供了证据表明,核糖核酸酶诱导选择性凋亡作用中最重要的因素是这些酶的结构组织,它决定了它们与细胞成分的相互作用方式。关于核糖核酸酶与癌细胞之间非催化相互作用在选择性细胞毒性表现中占主导作用的新观点将有助于基于核糖核酸酶的抗肿瘤药物的开发。